Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Daniel Grosu; Tim Hall


Illumina has named Daniel Grosu to the newly created position of vice president and chief medical officer. Grosu will "play a key role in building Illumina's diagnostic capabilities through collaborations with regulatory agencies, internal product development teams, and Illumina's CLIA-certified clinical laboratory," the firm said.

Prior to joining Illumina, Grosu was group director of clinical science and clinical and medical affairs at Ortho-Clinical Diagnostics. He was also previously the director and global clinical leader of global clinical development for Bayer Healthcare Pharmaceuticals' diagnostic imaging business. Before that, Grosu worked at Siemens Medical Solutions.

He earned a medical degree from Saint Louis University and an MBA from the University of Oxford.

Oxford Gene Technology has tapped Tim Hall to be its new finance director as of January 2012.

Hall most recently was finance director of Lombard Medical Technologies. He also was director of strategic planning at Medeva and chief financial officer at Celltech Pharmaceuticals.

Hall has a business administration degree from the University of Bath in the UK and qualified as an accountant with Touche Ross.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.